Page 6 - 《中国药房》2022年7期
P. 6
Excavation and evaluation of adverse reaction signals of 4 kinds of imported PD-1/PD-L1 inhibitors ……………
……………………………………………………………… LI Changlong，SHU Jiahua，LI Guoxing，YU Xian（873）
Systematic review of efficacy and safety of fondaparinux in the treatment of non-ST-elevation acute coronary
syndrome in China ……………………………………………………………………………………………………
……………… XIE Xingxing，ZHANG Jie，FAN Xiaodong，LIU Yilong，HUANG Feihong，YU Bin，FAN Ling（879）
Continuing professional development model of Japanese pharmacists and its enlightenment ………………………
…………………………………………………………………………………………… LIU Yanli，WANG Yong（885）
Research progress on enteric-soluble soft capsule ……………………………………………………………………
… TAO Xiaoqian，FU Huimin，QIAO Zitong，ZHANG Qiang，BAO Ziwei，CHENG Lan，ZHANG Chungang（891）
CHINA PHARMACY （Semimonthly） Phone
Founded in January 1990 +86-23-63830521；+86-23-63830907；+86-23-68586727；
Vol.33，No.7，Apr. 2022 +86-23-68586827
Total No.721 Published on Apr. 15，2022 E-mail
info@china-pharmacy.com
Responsible Institution info@pharmacyvision.net
National Health Commission，P.R. China Website
Sponsored by http：//www.china-pharmacy.com
Chinese Hospital Association http：//www.pharmacyvision.net
Chongqing University Cancer Hospital Online Submission
Edited by http：//2018.china-pharmacy.com
China Pharmacy Editorial and Publishing Center http：//papers.pharmacyvision.net
Director of Editorial Commission Printed by
LI Linkang Chongqing Changhong Printing Co.，Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China：Chongqing Post Offices（Code No.78-33）
Editor-in-Chief Overseas：China International Book Trading Corporation
HU Xin （Code No.4703SM）
Vice Editor-in-Chief Subscription Rates
LENG Huaiming
Chief Editor CNY 15 per issue；CNY 360 per annum
XIA Peiyuan CSSN ISSN 1001-0408
Published by CN 50-1055/R
China Pharmacy Editorial Department CODEN
Postal Address ZYHAA4
129 Daping Main Street，Yuzhong District，Chongqing Perennial Legal Counsel
400042，China Chongqing Huali Wantao Law Firm
